AksharChem Financial Statements

AksharChem (AKSHARCHEM) reported revenue of ₹3.47B in FY2025 with net income of ₹47.70M. Total assets stood at ₹4.15B and free cash flow was -₹93.80M.

AksharChem Income Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Revenue		3.02B	3.47B
Cost of Rev. Cost of Revenue		-1.81B	-2.11B
Gross Profit		1.21B	1.35B
SGA Sales, General & Admin		-1.19B	-1.23B
Op. Income Operating Income		-118.35M	-23.02M
PBT Profit Before Tax		-155.62M	58.26M
Net Income		-186.77M	47.70M
Dil. Shares Diluted Shares		8.03M	8.03M
Diluted EPS		-23.25	5.94

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows AksharChem's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

AksharChem Balance Sheet

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Curr. assets Total current assets		1.30B	1.34B
Non-curr. assets Total non-current assets		2.50B	2.81B
Total assets		3.81B	4.15B
Curr. liabilities Total current liabilities		819.64M	1.15B
Non-curr. liab. Total non-current liabilities		393.51M	362.07M
Total liabilities		1.21B	1.52B
Total equity		2.59B	2.64B
Total liab. & eq. Total liabilities & equity		3.81B	4.15B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures AksharChem's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

AksharChem Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Net Income		-155.62M	58.26M
Operating CF Cash flow Operating Activities		-65.55M	348.23M
Capex Investments in PPE		-168.45M	-442.03M
Investing CF Cash flow Investing Activities		-164.03M	-440.29M
Dividend Paid		-3.99M	-3.95M
Financing CF Cash flow Financing Activities		229.71M	91.91M
Cash (start) Cash at beginning of period		1.47M	1.60M
Cash (end) Cash at end of period		1.60M	1.44M
FCF Free Cash Flow		-234.00M	-93.80M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how AksharChem's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025